Metrics
Publication
152
Open Access
11
UN Sustainable Development Goals
Education
2008 - 2015
2008 - 2015Doctorate
Istanbul University, Health Sciences Institute, Deneysel Tıp Araştırma Enstitüsü Genetik Ad, Turkey
2005 - 2008
2005 - 2008Postgraduate
Istanbul University, Deneysel Tıp Araştırma Enstitüsü, Genetik Ad., Turkey
2001 - 2005
2001 - 2005Undergraduate
Istanbul University, Cerrahpaşa Tıp Fakültesi, Tıbbi Biyolojik Bilimler, Turkey
Dissertations
2015
2015Doctorate
Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom Analizleri
Istanbul University, Deneysel Tıp Araştırma Enstitüsü, Genetik Ad.
2008
2008Postgraduate
T-ALL Hastalarında NOTCH1 Mutasyonunun Araştırılması
Istanbul University, Deneysel Tıp Araştırma Enstitüsü, Genetik Ad.
Research Areas
Medicine
Life Sciences
Molecular Biology and Genetics
Moleculer Biology of Cancer
Health Sciences
Fundamental Medical Sciences
Natural Sciences
Academic Positions
2020 - 2022
2020 - 2022Researcher
U1310
Supervised Theses
2019
2019Postgraduate
AKUT LÖSEMI HASTALARINDA “ZINC FINGER PROTEIN 384” (ZNF384) GENİ FÜZYONLARININ TESPİTİ
Sayitoğlu M., Erbilgin Y. (Co-Advisor)
T.Sudutan(Student)
Articles
All (39)
SCI-E, SSCI, AHCI (32)
SCI-E, SSCI, AHCI, ESCI (33)
ESCI (1)
Scopus (32)
TRDizin (9)
Other Publications (4)
2025
20251. Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling.
Wenson L., Heldin J., Martin M., Erbilgin Y., Salman B., Sundqvist A., et al.
Nature communications
, vol.16, no.1, pp.7130, 2025 (SCI-Expanded)
2025
20252. Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients
Erbilgin Y., Firtina S., Kirat E., Khodzhaev K., Karakas Z., Ünüvar A., et al.
BIOCHEMICAL GENETICS
, 2025 (SCI-Expanded, Scopus)
2025
20253. Filaggrin Gene Variants Among Patients With Atopic Dermatitis in Turkey: A Multicenter Study Investigating Its Relationship With Disease Severity and Clinical/Laboratory Findings
Erdem Y., Özkaya E., Erbilgin Y., Saritas M., Sayitoğlu M., Kucuk O. S., et al.
DERMATITIS
, 2025 (SCI-Expanded)
2024
20244. A novel germline Pregnane X Receptor (PXR) variant predisposing to Hodgkin lymphoma in two siblings.
Khodzhaev K., Sudutan T., Erbilgin Y., Saritas M., Yegen G., Bozkurt C., et al.
European journal of medical genetics
, vol.72, pp.104975, 2024 (SCI-Expanded)
2023
20235. Mediterranean Journal of Hematology and Infectious Diseases
Qipa E., Acar M., Bozkurt S., Buyukdogan M., Sonmez H. B., Sayitoglu M., et al.
MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES
, no.1, 2023 (SCI-Expanded, Scopus)
2023
20236. Perception and management of cancer predisposition in pediatric cancer centers: A European-wide questionnaire-based survey
Lazic J., Haas O. A., Özbek U., Ripperger T., Byrjalsen A., Te Kronnie G., et al.
Pediatric Blood and Cancer
, vol.70, no.5, 2023 (SCI-Expanded)
2023
20237. Impact of TP53 gene variants on prognosis and survival of childhood acute lymphoblastic leukemia.
Firtina S., Erbilgin Y., Hatirnaz Ng O., Karaman S., Karakas Z., Celkan T. T., et al.
Scandinavian journal of clinical and laboratory investigation
, vol.83, no.3, pp.187-193, 2023 (SCI-Expanded, Scopus)
2023
20238. Modeling Blast Crisis Using Mutagenized Chronic Myeloid Leukemia-Derived Induced Pluripotent Stem Cells (iPSCs)
Imeri J., Desterke C., Marcoux P., Telliam G., Sanekli S., Barreau S., et al.
Cells
, vol.12, no.4, 2023 (SCI-Expanded)
2023
20239. Obstacles and expectations of rare disease patients and their families in Turkiye: ISTisNA project survey results
HATIRNAZ NG Ö., Sahin I., ERBİLGİN Y., ÖZDEMİR Ö., YÜCESAN E., Erturk N., et al.
FRONTIERS IN PUBLIC HEALTH
, vol.10, 2023 (SCI-Expanded)
2022
202210. Zinc finger protein 384 (ZNF384) impact on childhood mixed phenotype acute leukemia and B-cell precursor acute lymphoblastic leukemia.
Sudutan T., Erbilgin Y., Hatirnaz Ng O., Karaman S., Karakas Z., Kucukcankurt F., et al.
Leukemia & lymphoma
, vol.63, no.12, pp.2931-2939, 2022 (SCI-Expanded, Scopus)
2021
202111. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia
Erbilgin Y., Hatirnaz Ng O., Can I., Firtina S., Kucukcankurt F., Karaman S., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
, vol.43, no.5, pp.1093-1103, 2021 (SCI-Expanded, Scopus)
2021
202112. Differential Expression of LEF1 Isoforms in Adult Lymphoid and Myeloid Malignancies
FIRTINA S., HATIRNAZ NG Ö., ERBİLGİN Y., HAZNEDAROĞLU İ. C., SAYİTOĞLU M.
Experimed , vol.11, 2021 (Peer-Reviewed Journal)
2020
202013. HighTUBB2Aexpression in childhood T-ALL is correlated with the clinical outcome
Khodzhaev K., Ng O. H., Tuğcu D., Erbilgin Y., Ng Y. Y., Celkan T., et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY
, vol.42, no.5, pp.581-588, 2020 (SCI-Expanded)
2020
202014. Lymphoma Predisposing Gene in an Extended Family: CD70 Signaling Defect
Khodzhaev K., Bay S., Kebudi R., Altindirek D., Kaya A., Erbilgin Y., et al.
JOURNAL OF CLINICAL IMMUNOLOGY
, vol.40, no.6, pp.883-892, 2020 (SCI-Expanded)
2020
202015. PTEN and AKT1 Variations in Childhood T-Cell Acute Lymphoblastic Leukemia
Küçükcankurt F., Erbilgin Y., Fırtına S., Hatırnaz N., Karakaş Z., Celkan T., et al.
TURKISH JOURNAL OF HEMATOLOGY
, vol.37, no.2, pp.98-103, 2020 (SCI-Expanded, Scopus, TRDizin)
2019
201916. Prognostic gene alterations and clonal changes in childhood B-ALL
Erbilgin Y., Firtina S., Mercan S., Ng O. H., Karaman S., Tasar O., et al.
LEUKEMIA RESEARCH
, vol.83, 2019 (SCI-Expanded, Scopus)
2019
201917. Deep sequencing of BCR-ABL1 kinase domain mutations in chronic myeloid leukemia patients with resistance to tyrosine kinase inhibitors
Erbilgin Y., Eskazan A. E., Ng O. H., Salihoglu A., Elverdi T., Firtina S., et al.
LEUKEMIA & LYMPHOMA
, vol.60, pp.200-207, 2019 (SCI-Expanded)
2018
201818. Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data on a single center experience along with the review of the literature.
Ongoren S., Eskazan A. E., Suzan V., Savci S., Ozunal I. E., Berk S., et al.
Hematology (Amsterdam, Netherlands)
, vol.23, no.4, pp.212-220, 2018 (SCI-Expanded)
2018
201819. Prevalence and effect evaluation of FLT3 and NPM1 mutations in acute myeloid leukemia patients in eastern Algeria
Ayachı O. S., Rezgoun M. L., Sayitoglu M., Altindirek D., Erbilgin Y., Abadı N., et al.
UHOD - Uluslararasi Hematoloji-Onkoloji Dergisi
, vol.28, no.3, pp.169-179, 2018 (SCI-Expanded)
2017
201720. Dysregulation of the DKK1 gene in pediatric B-cell acute lymphoblastic leukemia.
Fırtına S., Hatırnaz N. O., Erbilgin Y., Özbek U., Sayitoğlu M.
Turkish journal of medical sciences
, vol.47, pp.357-363, 2017 (SCI-Expanded)
2017
201721. Aberrant Hypermethylation of APC Tumor Supressor Gene in Acute Leukemia Patients
Hatirnaz O. N. G., Firtina S., Erbilgin Y., Özbek U., Sayitoglu M.
UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI
, vol.27, pp.1-7, 2017 (SCI-Expanded)
2016
201622. Çocukluk Çag ı Akut Lenfoblastik Lösemide Genetik Belirteçler
ERBİLGİN Y., ÖZBEK U.
Turkiye Klinikleri J Pediatr Sci , vol.12, no.4, 2016 (Peer-Reviewed Journal)
2014
201423. Local Renin-Angiotensin system in normal hematopoietic and multiple myeloma-related progenitor cells.
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Hatirnaz O., AKSU S., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.31, no.2, pp.136-42, 2014 (SCI-Expanded)
2014
201424. Deregulated WNT signaling in childhood T-cell acute lymphoblastic leukemia.
Ng O. H., Erbilgin Y., Firtina S., Celkan T., Karakas Z., Aydogan G., et al.
Blood cancer journal
, vol.4, 2014 (SCI-Expanded, Scopus)
2013
201325. Local hematopoietic renin-angiotensin system in myeloid versus lymphoid hematological neoplastic disorders.
Uz B., Tatonyan S. C., Sayitoglu M., Erbilgin Y., Ng O. H., BÜYÜKAŞIK Y., et al.
Journal of the renin-angiotensin-aldosterone system : JRAAS
, vol.14, no.4, pp.308-14, 2013 (SCI-Expanded)
2013
201326. Parallel Visualization of Multiple Protein Complexes in Individual Cells in Tumor Tissue
Leuchowius K., Clausson C., Grannas K., Erbilgin Y., Botling J., Zieba A., et al.
MOLECULAR & CELLULAR PROTEOMICS
, vol.12, no.6, pp.1563-1571, 2013 (SCI-Expanded)
2012
201227. Upregulation of T-Cell-Specific Transcription Factor Expression in Pediatric T-Cell Acute Lymphoblastic Leukemia (T-ALL).
Sayitoglu M., Erbilgin Y., Ng O. H., Yildiz I., Celkan T., Anak S., et al.
Turkish journal of haematology : official journal of Turkish Society of Haematology
, vol.29, no.4, pp.325-33, 2012 (SCI-Expanded)
2012
201228. Elevated TRIB2 with NOTCH1 activation in paediatric/adult T-ALL.
Hannon M. M., Lohan F., Erbilgin Y., Sayitoglu M., O'hagan K., Mills K., et al.
British journal of haematology
, vol.158, no.5, pp.626-34, 2012 (SCI-Expanded)
2012
201229. Akut lösemi hücre serilerinde beta-katenin sirna uygulamaları
HATIRNAZ O., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
Deneysel Tıp Dergisi , vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)
2012
201230. Genetic alterations in members of the Wnt pathway in acute leukemia
Erbilgin Y., Ng O. H., Mavi N., Ozbek U., Sayitoglu M.
LEUKEMIA & LYMPHOMA
, vol.53, pp.508-510, 2012 (SCI-Expanded)
2012
201231. Akut Lösemi Hücre Serilerinde Beta-Katenin siRNA Uygulamaları
HATIRNAZ NG Ö., ERBİLGİN Y., AKTAŞ E., DENİZ G., ÖZBEK U., SAYİTOĞLU M.
Deneysel Tıp Araştırma Enstitüsü Dergisi , vol.2, no.3, pp.16-22, 2012 (Peer-Reviewed Journal)
2012
201232. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia.
Firtina S., Sayitoglu M., Hatirnaz O., Erbilgin Y., Oztunc C., Cinar S., et al.
Leukemia research
, vol.36, no.1, pp.87-92, 2012 (SCI-Expanded, Scopus)
2011
201133. Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: Is that true for all the patients?
Eskazan A. E., Soysal T., Erbilgin Y., Ozbek U., Ferhanoglu B.
LEUKEMIA RESEARCH
, vol.35, no.9, 2011 (SCI-Expanded)
2011
201134. BETA KATENİN VE AXIN2 PROTEİNLERİ ETKİLEŞİMLERİNİN PROKSİMİTİ LİGASYON ASSAY YAKINSAL BAĞLANMA TESPİTİ ILE GÖRÜNTÜLENMESİ
ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., SÖDERBERG O., ÖZBEK U.
DENEYSEL TIP DERGİSİ , vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)
2011
201135. ABL gene kinase domain mutation scanning by denaturing high performance liquid chromatography sequencing method
Erbilgin Y., Catal S., Eskazan A. E., Hatirnaz O., Soysal T., Ozbek U.
TURKISH JOURNAL OF HEMATOLOGY
, vol.28, no.2, pp.97-102, 2011 (SCI-Expanded)
2011
201136. ß Katenin ve Axin2 proteinleri etkileşimlerinin Proksimiti LigasyonAssay Yakınsal Bağlanma Tespiti ile görüntülenmesi
ERBİLGİN Y., SAYİTOĞLU M., SODERBERG O., HATIRNAZ NG Ö., ÖZBEK U.
Deneysel Tıp Dergisi , vol.1, no.2, pp.24-27, 2011 (Peer-Reviewed Journal)
2011
201137. Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
Uz B., Bektas O., Eliacik E., GÖKER H., ERBİLGİN Y., SAYİTOĞLU M., et al.
CASE REPORTS IN HEMATOLOGY
, 2011 (ESCI)
2010
201038. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL
Erbilgin Y., Sayitoglu M., Hatirnaz O., Dogru O., Akçay A., TUYSUZ G., et al.
DISEASE MARKERS
, vol.28, no.6, pp.353-360, 2010 (SCI-Expanded)
2009
200939. Effects of imatinib mesylate on renin-angiotensin system (RAS) activity during the clinical course of chronic myeloid leukaemia.
Sayitoglu M., Haznedaroğlu İ. C., Hatirnaz O., Erbilgin Y., Aksu S., Koca E., et al.
The Journal of international medical research
, vol.37, no.4, pp.1018-28, 2009 (SCI-Expanded)
Papers Presented at Peer-Reviewed Scientific Conferences
2025
20251. Deciphering congenital hemolytic anemia: identifying causal variants in unresolved cases through whole exome sequencing
Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Ünal Cangül Ş., Küpesiz O. A., et al.
European Human Genetics Conference, Milan, Italy, 24 - 27 May 2025, pp.1-2, (Summary Text)
2024
20242. HODGKİN LENFOMAYA KALITSAL YATKINLIK OLUŞTURAN YENİ BİR GEN: PREGNANE X RESEPTÖRÜ (PXR)
Sudutan T., Khodzhaev K., ERBİLGİN Y., SARITAŞ M., YEGEN G., Bozkurt C., et al.
50. Ulusal Hematoloji Kongresi, Turkey, 30 October 2024, (Summary Text)
2024
20243. Ethical, Legal, and Social ImplicaKons (ELSI) of Biobanking in Turkey
ERBİLGİN Y.
ETHICAL, LEGAL AND SOCIETAL INSIGHTS & OUTLOOK FOR BIOBANKS AND MEDICAL RESEARCH, Lyon, France, 4 - 07 June 2024, (Summary Text)
2024
20244. A Novel FBN1 Variant in A Large Marfan Family with High Penetrance of Aortic Features
ERBİLGİN Y., ÇEFLE K., ÖZTÜRK Ş., EKIJI L., KADIOĞLU P., Kocaağa S., et al.
Avrupa İnsan Genetiği Kongresi 2024, Berlin, Germany, 01 June 2024, (Summary Text)
2024
20245. ISTisNA Platform: A Comprehensive Biobank Network for Rare and Undiagnosed Diseases
Antmen F. M., KASAP B., Erdogan C., Kılıç M., Kocaaga S., Önder G., et al.
Europe Biobank Week Congress 2024, Viyana, Austria, 14 - 17 May 2024, (Summary Text)
2024
20246. Exploring Germline Variations and Predisposition in Childhood Lymphoma
Sudutan T., Khodhzaev K., Erbilgin Y., Altındirek D., Kocaağa S., Sarıtaş M., et al.
Avrupa İnsan Genetiği Kongresi (ESHG), Berlin, Germany, 01 May 2024, (Unpublished)
2023
20237. Hereditary hemolytic anemia cases in Turkey by whole exome sequencing
Altındirek D., ERBİLGİN Y., KARAKAŞ Z., KARAMAN S., TUĞCU D., SAYİTOĞLU M.
EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects, Budapest, Hungary, 3 - 04 November 2023, (Full Text)
2023
20238. FOLİKÜLER LENFOMALI HASTALARDA FOLİKÜLER SİTOTOKSİK T HÜCRELERİ
Akboğa F., Kuyaş M. İ., Hindilerden F., Yönal Hindilerden İ., Gültürk E., Erbilgin Y., et al.
26. Ulusal İmmünoloji Kongresi, Ankara, Turkey, 11 - 13 November 2023, pp.49, (Summary Text)
2023
20239. Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk
Altındirek D., TUĞCU D., ERBİLGİN Y., KARAMAN S., SAYİTOĞLU M., TANYILDIZ H. G., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Summary Text)
2023
202310. Foliküler Lenfomalı Hastalarda Foliküler Sitotoksik T Hücre Alt Grupları ve Fonksiyonları
Akboğa F., Kuyaş M. İ., HİNDİLERDEN F., YÖNAL HİNDİLERDEN İ., Gültürk E., ERBİLGİN Y., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)
2023
202311. Nadir Bir Anemi: Konjenital Diseritropoetik Anemi Tip1’de De Novo CDIN1 Gen Varyasyonu ve Birleşik Heterozigotluk
Altındirek D., Tuğcu D., Erbilgin Y., Karaman S., Sayitoğlu M., Tanyıldız H. G., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, (Unpublished)
2023
202312. Makine Öğrenmesi Temelli Transkriptom Modeli Kullanarak Ph-Benzeri ALL Hastalarının Tespiti
Sun E., ULUCAN AÇAN Ö., ERBİLGİN Y., EŞKAZAN A. E., KARAKAŞ Z., SAYİTOĞLU M.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)
2023
202313. Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık
Khodzhaev K., SUDUTAN T., ERBİLGİN Y., Ocak S., KIYKIM A., Altındirek D., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2023, (Summary Text)
2023
202314. Çocukluk Çağı Lenfoma Hastalarında Germline Varyasyonlar ve Genetik Yatkınlık
Khozhaev K., Sudutan T., Erbilgin Y., Ocak S., Kıykım A., Altındirek D., et al.
49. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2023, pp.1-2, (Summary Text)
2023
202315. Characterization of Hereditary Hemolytic Anemia cases in Turkey by Whole Exome Sequencing
Altındirek D., Tuğcu D., Karaman S., Erbilgin Y., Sayitoğlu M., Karakaş Z.
EHA-SWG Scientific Meeting on Red Cell and Iron Metabolism Defects: From Basic Science to Clinical Case Application, Budapest, Hungary, 12 - 14 October 2023, (Unpublished)
2023
202316. BCL11b Mutasyonuna Bağlı Kombine İmmün Yetmezliği Olan Bir Hastada Kazanılmış Hemofili
ŞAHİN Ş., KARAMAN S., ERBİLGİN Y., ASLANGER A. D., GEZDİRİCİ A., TUĞCU D., et al.
14. Ulusal Pediatrik Hematoloji Kongresi, Ankara, Turkey, 24 May 2023, (Summary Text)
2022
202217. The Anti-HIV Drug Nelfinavir Exhibits Synergistic Activity with Tyrosine Kinase Inhibitors and Circumvents TKI-Resistance Conferred By T315I-Mutated BCR-ABL
ERBİLGİN Y., Desterke C., Bennaceur Griscelli A., TURHAN A.
64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 - 13 December 2022, pp.3871-3872, (Full Text)
2022
202218. Modeling Progression of CML Using Mutagenized Patient-Derived Induced Pluripotent Stem Cells (iPSCs): Potential Tool for Discovering Novel Therapeutic Targets
Imeri J., Desterke C., Telliam G., Marcoux P., Sorel N., Sanekli S., et al.
64th American Society of Hematology Meeting, New Orleans, United States Of America, 10 December - 13 November 2022, pp.12173-12174, (Summary Text)
2022
202219. KRONİK MİYELOİD LÖSEMİ HASTALARINDA FARKLI BCR::ABL1 TRANSKRİPTLERİNİN KLİNİK YANSIMALARI
Ordu M., Erbilgin Y., Yılmaz U., Eşkazan A. E., Altındirek D., Uğur İşeri S. A., et al.
48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, pp.126-127, (Full Text)
2022
202220. KONJENİTAL HEMOLİTİK ANEMİ HASTALARINDA TÜM EKZOM DİZİLEME İLE ADAY VARYANTLARIN BELİRLENMESİ
ALTINDİREK D., TUĞCU D., BİLİCİ M., KARAMAN S., ERBİLGİN Y., ÜNAL CANGÜL Ş., et al.
48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 01 November 2022, (Full Text)
2022
202221. ÇOCUKLUK ÇAĞI BİFENOTİPİK AKUT LÖSEMİ HASTALARINDA MOLEKÜLER BELİRTEÇLER VE PROGNOSTİK ÖNEMİ
KÜÇÜKCANKURT F., ERBİLGİN Y., Sudutan T., KARAKAŞ Z., KARAMAN S., ÖZDEMİR G. N., et al.
48. Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 05 November 2022, (Full Text)
2021
202122. Lenfoma ve İmmünyetmezliğe Sahip İndeks Olguda Somatik ve Germline Varyasyonların Ekzom Dizi Analizi ile Analizi
Khodzhaev K., SARITAŞ M., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.
XIII. AZİZ SANCAR DENEYSEL TIP ARAŞTIRMA ENSTİTÜSÜ GÜNLERİ Yaşam Bilimlerinde Omik Teknolojileri: Genomdan Tedaviye, İstanbul, Turkey, 21 - 22 December 2021, vol.12, (Summary Text)
2021
202123. A Novel Candidate Gene for Predisposition of Hodgkin Lymphoma; Pregnan X Receptor (PXR)
KEBUDİ R., ERBİLGİN Y., Khodzhaev K., Sarıtaş M., BOZKURT C., SAYİTOĞLU M.
63RD ASH ANNUAL MEETING, United States Of America, 11 December 2021, (Full Text)
2021
202124. Prognostic evidence of LEF1 isoforms in childhood acute lymphoblastic leukemia
ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., Küçükcankurt F., KARAKAŞ Z., CELKAN T. T., et al.
European Human Genetics Virtual Conference 2021, Austria, 28 - 31 August 2021, (Summary Text)
0
025. Wnt Sinyal İleti Yolunun T-Hücreli ve B-Hücreli Akut Lenfoblastik Lösemilerde Farklı Aktivasyonları
SAYİTOĞLU M., HATIRNAZ O., ATALAR F., ERBİLGİN Y., ÖZBEK U.
XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, pp.75, (Full Text)
2019
201926. Gen Ekspresyon Verilerinin Meta-Analizi ile Pediatrik Akut Lenfoblastik Lösemi’xxde Nükse Özgü Belirteçlerin Tespiti
ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.
45. Ulusal Hematoloji Kongresi, Turkey, 31 October - 02 November 2019, (Full Text)
2019
201927. Akut Lösemili Hastalarda ’xx’xx Zinc Finger Protein 384’xx’xx (ZNF384) Geni Füzyonlarının Tespiti
Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAMAN S., SARPER N., CELKAN T. T., et al.
45. Ulusal Hematoloji Kongresi, Turkey, 30 October - 02 November 2019, (Summary Text)
2019
201928. CD70 mutations in a family with affected CID indivuduals
Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M.
Highlights of Bertinoro, Predisposition to hereditary Leukemia and Lymphoma Training School, 11 - 12 October 2019, (Full Text)
2019
201929. Whole Genome Expression Profiling at Diagnosis Predicts Relapse in Childhood Acute Lymphoblastic Leukemia
ERBİLGİN Y., Khodzhaev K., SAYİTOĞLU M.
7th International Congress on Leukemia Lymphoma Myeloma, 3 - 04 May 2019, (Full Text)
2019
201930. Determination of Zinc Finger Protein 384 (ZNF384) Gene Fusion in Childhood Acute Lymphoblastic Leukemia Patients
Sudutan T., ERBİLGİN Y., HATIRNAZ NG Ö., KARAKAŞ Z., SARPER N., CELKAN T. T., et al.
13th Balkan Congress of Human Genetics, 17 - 20 April 2019, (Full Text)
2018
201831. T-akut lenfoblastik lösemi (T-ALL) Hastalarında Yüksek TUBB2A Gen Anlatımı ve siRNA Aracılı Modülasyonu
Khodzhaev K., HATIRNAZ NG Ö., TUĞCU D., Ng Y. Y., ERBİLGİN Y., CELKAN T. T., et al.
13. Ulusal Tıbbi Genetik Kongresi, Turkey, 7 November - 11 October 2018, (Summary Text)
2018
201832. Kanda serbest dolaşan tümör cDNA’larının lenfoma alt gruplarının tanımlanmasında ve hastalık takibinde kullanımının araştırılması
ERBİLGİN Y.
44.Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2018, (Summary Text)
2018
201833. A translational perspective on diffuse large B-cell lymphoma
Erbilgin Y.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)
2018
201834. Comprehensive analysis of transcriptomic portrait of T-cell acute lymphoblastic leukemia by RNA sequencing
Sun E., Ng O. H., Erbilgin Y., Firtina S., Sayitoglu M.
9th International Eurasian Hematology Oncology Congress (EHOC), İstanbul, Turkey, 17 - 20 October 2018, vol.73, (Summary Text)
2018
201835. Nörogenetik verinin analizi: İnteraktif eğitim ve uygulama- ACMG Klavuzu
ERBİLGİN Y.
Nadir Görülen Hastalıklar Sempozyumu ve Nörogenetik Kursu, Turkey, 31 May 2018, (Summary Text)
2018
201836. AccessDistribution of Biospecimens: Practical Issues
ERBİLGİN Y.
International Workshop on Biobanking for Rare Diseases, 2 - 03 May 2018, (Full Text)
2017
201737. IKZF1 Deletions at Diagnose and Relapse of Childhood B-ALL
Erbilgin Y., Firtina S., NG O. H., CELKAN T., Karakas Z., Anak S. S., et al.
59th Annual Meeting of the American-Society-of-Hematology (ASH), Georgia, United States Of America, 9 - 12 December 2017, vol.130, (Summary Text)
2017
201738. Çocukluk Çağı B-All Gelişiminde Kanonik Olmayan Wnt Yolağı Prognoz ve Sağ Kalım İle İlişkili Olabilir
HATIRNAZ N. Ö., FIRTINA S., AKGÜN E., TAKA E., ERBİLGİN Y., CELKAN T. T., et al.
43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201739. Çocukluk Çağı B-All Hastalarında Tanı Ve Nüks Anındaki Moleküler Değişimlerin Dinamiği
FIRTINA S., ERBİLGİN Y., TAŞAR O., MERCAN S., HATIRNAZ N. Ö., şişko s., et al.
43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201740. Çocukluk Çağı B-ALL Hastalarında IKZF1 Delesyonlarının Araştırılması
ERBİLGİN Y., FIRTINA S., khodzhaev k., HATIRNAZ N. Ö., KARAKAŞ Z., CELKAN T. T., et al.
43. Ulusal hematoloji kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201741. Çocukluk Çağı B-ALL Hastalarinda IKZF1 Delesyonlarinin Araştırılması
ERBİLGİN Y., HATIRNAZ NG Ö., SAYİTOĞLU M., ÖZBEK U.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201742. Çocukluk Çağı T Hücreli Akut Lenfoblastik Lösemi Hastalarında Artmış TUBB2A Anlatımı Tedavi Yanıtını Belirler
KHODZHAEV K., HATIRNAZ NG Ö., TUĞCU D., ERBİLGİN Y., CELKAN T. T., KARAKAŞ Z., et al.
43. Ulusal Hematoloji Kongresi, Turkey, 1 - 04 November 2017, (Summary Text)
2017
201743. C¸OCUKLUK C¸AGˆI B-ALL HASTALARINDA IKZF1 DELESYONLARININ ARAS¸TIRILMASI
ERBİLGİN Y., Firtina S., Khodzhaev K., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T., et al.
43 Ulusal Hematoloji Kongresi, Antalya, Turkey, 1 - 04 November 2017, pp.13, (Summary Text)
2017
201744. T-AKUT LENFOBLASTİK LÖSEMİ’DE TRANSKRİPTOM DİZİLEME ANALİZLERİ
Sun E., HATIRNAZ NG Ö., Firtina S., ERBİLGİN Y., SAYİTOĞLU M.
50. Ulusal Hematoloji KOngresi, Antalya, Turkey, 1 - 04 November 2017, pp.12, (Full Text)
2017
201745. Research Biobank for Leukemia
ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., khodzhaev k., ÖZBEK U., SAYİTOĞLU M.
Towards Harmony in Biobanking, 13 - 15 September 2017, (Summary Text)
2017
201746. Outcomes of a Biobanking Initiative from Turkey: ‘Investing in the Future: BIOBANK
ERBİLGİN Y., TUNCER F. N., UĞUR İŞERİ S. A., Khodzhaev K., ÖZBEK U.
Global Biobank Week, 13 - 15 September 2017, (Summary Text)
2017
201747. Towards an Epilepsy Biobank
Haryanyan G., Özdemir Ö., Yücesan E., TUNCER F. N., Kesim F. Y., ERBİLGİN Y., et al.
Global Biobank Week, 13 - 15 September 2017, (Summary Text)
2017
201748. Does TUBB2A expression have a prognostic effect in childhood T-ALL patients
Khodzhaev K., HATIRNAZ NG Ö., ERBİLGİN Y., TUĞCU D., SAYİTOĞLU M.
6th International Congress on Leukemia Lymphoma Myeloma, 11 - 16 May 2017, (Summary Text)
2017
201749. PTEN AND AKT1 GENE VARIATIONS IN CHILDHOODT-ALL PATIENTS
Küçükcankurt F., HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., KARAKAŞ Z., CELKAN T. T., et al.
6th International Congress onLeukemia – Lymphoma – Myeloma, 11 - 13 May 2017, (Summary Text)
2017
201750. Comparative analysis of regenerative potential of dental pulp and dental follicle derived stem cells cultured on polycaprolactone scaffolds for bone tissue engineering approaches
Özcan E., ERBİLGİN Y.
23rd International Conference on Oral and Maxillofacial Surgery, 31 March - 03 April 2017, (Summary Text)
2016
201651. Pediatrik T ALL hastalarında regulator mikroRNA ların yolak analizleri ile belirlenmesi
HATIRNAZ NG Ö., Khodzhaev K., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
42 Ulusal Hematoloji Kongresi, Turkey, 19 - 22 October 2016, (Full Text)
2016
201652. Pre examination process requirements for European biobanks focus on venous whole blood
Linsen L., Baber R., Caboux E., Daidone M., ERBİLGİN Y., wilde A. D., et al.
European Biobank Week 2016, 13 - 16 September 2016
2016
201653. Investing in the Future BIOBANK
ERBİLGİN Y., TUNCER F. N., Haryanyan G., Khodzhaev K., UĞUR İŞERİ S. A., ÖZBEK U.
European Biobank Week 2016, 13 - 16 September 2016
2016
201654. General quality management system requirements for European biobanks focus on formalin fixed and paraffin embedded tissues
Bonin S., Stumptner C., Caboux E., wilde A. D., ERBİLGİN Y., Goethals S., et al.
European Biobank Week 2016, 13 - 16 September 2016
2016
201655. Improve human derived sample quality grade in European biobanks focus on snap frozen tissues on behalf of BBMRI ERIC Working Group 1 in the Work plan Quality
Daidone M., Baldacchio S., Barros F., Becker K., Caboux E., wilde M. D., et al.
European Biobank Week 2016, 13 - 16 September 2016
2016
201656. Biyobankalarda Pre Analitik Süreçler ve Standartlar
ERBİLGİN Y.
Biyobankada Laboratuvar Süreçleri Kursu, Turkey, 27 May - 28 June 2016
2016
201657. Pathway Analizi Enrichment Analizi
ERBİLGİN Y.
Biyobankalamada Veri Analizi Yöntemleri Kursu, Turkey, 30 - 31 May 2016
2016
201658. Gen expression paterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets
ERBİLGİN Y., İŞLEK B., FIRTINA S., HATIRNAZ NG Ö., İNAL A., DOĞAN P., et al.
ESHG, 24 - 27 May 2016, (Summary Text)
2016
201659. Gene expression patterns in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targets
ERBİLGİN Y., İşlek B., Fırtına S., HATIRNAZ NG Ö., İnal A., Doğan P., et al.
European Society of Human Genetics 2016, Barselona, Spain, 21 - 24 April 2016, (Summary Text)
2016
201660. Gene expression pattern in relapsed B cell acute lymphoblastic leukemia and potential therapeutic targetss
ERBİLGİN Y., İslek B., Firtina S., HATIRNAZ NG Ö., Inal A., Dogan P., et al.
ESHG, Barselona, Spain, 20 - 22 May 2016, (Summary Text)
2016
201661. PROGNOSTİC SİGNİFİCANCE OF IKZF1 DELETİONS İN CHİLDHOOD B ALL
ERBİLGİN Y., FIRTINA S., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
Bİ ANNUAL CHILDHOOD LEUKEMIA SYMPOSIUM, 25 April - 27 May 2016, (Summary Text)
2016
201662. Prognostic significance of IKZF1 Deletionsin Childhood B ALL
ERBİLGİN Y., Fırtına S., HATIRNAZ NG Ö., KARAKAŞ Z., CELKAN T. T., SARPER N., et al.
10.th Biennial Childhood Leukemia Sypmosium, 24 - 26 April 2016, (Summary Text)
2016
201663. Geleceğe Yatırım BİYOBANKA Projesi kapsamında Biyobankalama Protokolleri
ERBİLGİN Y.
Biyobankada Protokol ve Kalite Çalıştayı, Turkey, 06 April 2016
2015
201564. Hematolojik malignitelerde genetik belirteçler
ERBİLGİN Y., ÖZBEK U.
Ulusal Çocuk Genetik Sempozyumu, Turkey, 22 - 24 October 2015
2013
201365. Sensitivity Reproducibility and Clinical Utility Of Next Generation Sequencing NGS for BCR ABL1 Kinase Domain Mutation Screening Results From The CML Work Package Of The Iron II Interlaboratory RObustness Of Next Generation Sequencing International Study
SOVERINI S., ERNST T., KOHLMANN A., DE BENEDITTIS C., ALIKIAN M., FORONI L., et al.
55.th ASH Meeting 2013, 7 - 10 December 2013, vol.122
2015
201566. Pediatrik T ALL hastalarında regülatör mikroRNA ların yolak analizleri ile belirlenmesi
HATIRNAZ NG Ö., ERBİLGİN Y., ÖZBEK U., SAYİTOĞLU M.
14 Tıbbi Biyoloji ve Genetik Kongresi, Turkey, 27 - 30 October 2015, (Summary Text)
2015
201567. Pathways associated with relapse and high risk in childhood acute lymphoblastic leukemia
ERBİLGİN Y.
European Society of Human Genetics, Glasgow, United Kingdom, 6 - 09 June 2015, pp.445, (Full Text)
2015
201568. Downregulation of SnoN SKIL gene in T ALL
HATIRNAZ NG Ö., Orcun T., Yuk Yin N., ceren o., ERBİLGİN Y., SAYİTOĞLU M., et al.
European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015
2015
201569. Pathways associated with relapse and high risk in childhood ALL
ERBİLGİN Y., HATIRNAZ NG Ö., Burak İ., Sinem F., Tiraje C., ANAK S. S., et al.
European Society of Human Genetics Meeting, Glasgow, England, 6 - 09 June 2015
2015
201570. Pathways asociated with relapse and high risk in childhood acute lymphoblastic leukemia
ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., ANAK S. S., KARAKAŞ Z., SARPER N., et al.
ESHG 2015, 6 - 09 June 2015
2015
201571. Down regulation of SnoN SKIL gene in T cell acute lymphoblastic leukemia
HATIRNAZ NG Ö., ERBİLGİN Y., SAYİTOĞLU M., ÖZBEK U.
ESHG 2015, 6 - 09 June 2015
2015
201572. Downregulation of Sno SKIL gene in T ALL
HATIRNAZ NG Ö., Orcun T., Yuk Yin N., Ceren Ö., ERBİLGİN Y., SAYİTOĞLU M., et al.
5th International Leukemia Lymphoma Myeloma Meeting, İstanbul, Turkey, 21 - 23 May 2015
2015
201573. PATHWAYS ASSOCIATED WITH RELAPSE AND HIGH RISK CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
ERBİLGİN Y., HATIRNAZ NG O., ISLEK B., FIRTINA S., CELKAN T. T., ANAK S. S., et al.
EUROPEAN HUMAN GENETICS CONFERENCE 2015 GLASGOW, SCOTLAND, UK, 6 - 09 June 2015, vol.23, (Full Text)
2015
201574. Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom Analizleri
ERBİLGİN Y.
DETAE Genç Araştırıcılar Toplantısı, Turkey, 19 - 20 January 2015, (Summary Text)
2014
201475. İÜ DETAE MOLEKÜLER HEMATOLOJİ ÇALIŞMA GRUBU 1996 2014 YILLARI LÖSEMİLERİN MOLEKÜLER MONİTORİZASYONU
SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., ALTINDİREK D., SERBEST E., SIRMA EKMEKCİ S., et al.
6. DETAE GÜNLERİ, Turkey, 24 - 25 November 2014
2014
201476. Pediatrik Akut Lösemi Hastalarında LEF1 Mutasyon Analizi
TOZAN F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., TAŞAR O., MERCAN S., et al.
6. DETAE Günleri, Turkey, 24 - 25 November 2014, (Summary Text)
2014
201477. Pediatrik ALL Hastalarında LEF1 Mutasyon Analizi
KÜÇÜKCANKURT F., ERBİLGİN Y., CAN İ., HATIRNAZ N. Ö., MERCAN S., şişko s., et al.
40. Ulusal Hematoloji Kongresi, Turkey, 22 - 25 October 2014, (Summary Text)
2014
201478. ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİDE GENOM BOYU METİLASYON ANALİZLERİ
ERBİLGİN Y., HATIRNAZ NG Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
40. Ulusal Hematoloji Kongresi, Turkey, 22 October 2014, (Summary Text)
2014
201479. Epigenetic profile of early relapsed Childhood ALL
ERBİLGİN Y., AYDOGAN G., CELKAN T., SAYİTOĞLU M., HATIRNAZ N. Ö., KARAKAŞ Z., et al.
40 Ulusal Hematoloji Kongresi, Antalya, Turkey, 22 - 25 October 2014, pp.20, (Summary Text)
2013
201380. Next Generation Sequencing Of The BCR ABL1 Domain May Be Beneficial In Decision Makin
Emre E., ÖZBEK U., HATIRNAZ NG Ö., ERBİLGİN Y., SOYSAL T., SAYİTOĞLU M., et al.
55th Annual Meeting of the American-Society-of-Hematology, New Orleans, United States Of America, 7 - 10 December 2013, (Full Text)
2013
201381. Next-Generation Sequencing Of The BCR-ABL1 Domain May Be Beneficial In Decision Making Among Chronic Myeloid Leukemia Patients With Tyrosine Kinase Inhibitor Resistance
Erbilgin Y., Eskazan A. E., NG O. H., Salihoglu A., Elverdi T., Firtina S., et al.
55th Annual Meeting of the American-Society-of-Hematology, Louisiana, United States Of America, 7 - 10 December 2013, vol.122, (Summary Text)
2013
201382. Derin Dizi Analizi ile Pediatrik Akut Lenfoblastik Lösemi Hastalarında TP53 Gen Mutasyonlarının Saptanması ve Prognostik Önemi
FIRTINA S., ERBİLGİN Y., HATIRNAZ N. Ö., CAN İ., KARAKAŞ Z., CELKAN T. T., et al.
39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)
2013
201383. Çocuk Çağı Nüks Akut Lösemi Hastalarının Genetik ve Epigenetik Karakterizasyonu
ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
39. Ulusal Hematoloji Kongresi, Turkey, 23 - 26 October 2013, (Summary Text)
2013
201384. TİROZİN KİNAZ İNHİBİTÖRLERİNE DİRENÇLİ KRONİK MİYELOİD LÖSEMİ HASTALARINDA YENİ NESİL DİZİLEME TEKNİĞİ İLE BCR-ABL1 KİNAZ BÖLGESİ MUTASYONLARININ TESPİTİ
ERBİLGİN Y., EŞKAZAN A. E., HATIRNAZ NG Ö., SALİHOĞLU A., ELVERDİ T., FIRTINA S., et al.
39. Ulusal Hematoloji Kongresi, Antalya, Turkey, 23 October 2013, (Summary Text)
2013
201385. Whole genome methylation profile of relapsed childhood leukemia, Translating Epigenomes into Function: a Next-Generation Challenge for Human Disease
ERBİLGİN Y., HATIRNAZ N. Ö., FIRTINA S., CELKAN T. T., ANAK S. S., KARAKAŞ Z., et al.
FEBS Workshop, Germany, 13 - 16 October 2013, (Summary Text)
2013
201386. Normalization methods and analysis packages for 450k data analysis
ERBİLGİN Y.
High-Throughput Methylome Analysis & Its Impact on Human Health and Disease Workshop, İstanbul, Turkey, 31 May 2013, (Summary Text)
2013
201387. Yeni nesil dizileme yöntemi ile tanı ve nüks akut lösemi hastalarında Tp53 Mutasyonlarının araştırılması
FIRTINA S., CAN İ., HATIRNAZ N. Ö., ERBİLGİN Y., KARAKAŞ Z., CELKAN T. T., et al.
9. Ulusal Pediatrik Hematoloji Kongresi, Turkey, 24 - 28 May 2013, (Summary Text)
2013
201388. Çocukluk Çağı Nüks Akut Lenfoblastik Lösemi Hastalarında Tüm Genom SNP Array Analizi
ERBİLGİN Y., HATIRNAZ NG Ö., CELKAN T. T., FIRTINA S., Can İ., ÜNÜVAR A., et al.
9 Ulusal Pediatrik Hematoloji Kongresi, Van, Turkey, 24 May 2013, pp.8, (Summary Text)
2012
201289. Elevated Trib2 with Notch1 activation in pediatric adult T ALL
ERBİLGİN Y., ÖZBEK U., M Hannon M., Lohan F., O Hagan K., Mills K., et al.
BRITISH JOURNAL OF HAEMATOLOGY, Glasgow, England, 2 - 04 December 2012, vol.157, pp.6, (Summary Text)
2012
201290. Çocukluk Çağı Nüks Akut Lösemi Hastalarında Tüm Genom Analizleri Ön Bulgular
ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ N. Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU L., et al.
38. Ulusal Hematoloji Kongresi, Turkey, 31 October - 03 November 2012, (Summary Text)
2012
201291. ÇOCUKLUK ÇAĞI NÜKS AKUT LÖSEMİ HASTALARINDA TÜM GENOM ANALİZLERİ; ÖN BULGULAR
ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., FIRTINA S., ÖZGÜVEN A. A., AĞAOĞLU ÜLGÜR F. L., et al.
38 Ulusal Hematoloji Kongresi, Turkey, 31 October 2012, (Summary Text)
2012
201292. Evaluation of PAX5 gene in the early stages of leukemic B cells in the childhood B cell acute lymphoblastic leukemia
FIRTINA S., SAYİTOĞLU M., HATIRNAZ N. Ö., ERBİLGİN Y., ÖZTUNÇ C., ÇINAR S., et al.
Molecular Immunology Immunogenetics Congress, Turkey, 27 - 29 April 2012, (Summary Text)
2011
201193. BCR-ABL TRANSKRİPTİNİN KANTİTATİF TAYİNİNDE ULUSLARARASI SKALAYA GEÇİŞ
HATIRNAZ NG Ö., ERBİLGİN Y., Çatal S., Öztunç C., Uğurel E., KARABULUT A., et al.
37. Ulusal Hematoloji Kongresi, Antalya, Turkey, 19 - 22 October 2011, (Summary Text)
2011
201194. A new noncoding risk factor for ALL 8q24 region preliminary data
Ismail C., HATIRNAZ NG Ö., ERBİLGİN Y., Ceren O., SAYİTOĞLU M., ugur o., et al.
3rd EMBO meeting, Viyana, Austria, 11 - 13 September 2011
2010
201095. Mutations in AXIN1, APC and B-catenin Genes in T-cell Acute Leukemia Patients
SAYİTOĞLU M., ÖZBEK U., ERBİLGİN Y.
T-cell Acute Lymphoblastic Leukemia (T-ALL) Meets Normal T-cell Development, Mandelieu, France, 7 - 09 May 2010, pp.28, (Full Text)
2009
200996. B HÜCRELİ AKUT LENFOBLASTİK LÖSEMİ HASTALARINDA PAX5 GENİ MOLEKÜLER ANALİZLERİ
ÖZDEMİRLİ S., SAYİTOĞLU M., HATIRNAZ NG Ö., ERBİLGİN Y., MAVİ N., TİMUR Ç., et al.
35.ULUSAL HEMATOLOJİ KONGRESİ, Turkey, 7 - 10 November 2009
2009
200997. T-ALL OLGULARINDA NOTCH1 VE FBXW7 GEN MUTASYONLARININ ARAŞTIRILMASI
ERBİLGİN Y., SAYİTOĞLU M., HATIRNAZ NG Ö., AR M. C., DOĞRU Ö., Aydoğan G., et al.
35. Ulusal Hematoloji Kongresi, Antalya, Turkey, 07 October 2009, (Summary Text)
2007
200798. Increased level of B-catenin mRNA and mutational alterations in APC gene are present in acute leukemia
ATALAR F., Sayitoglu M., HATIMAZ O., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.62, (Summary Text)
2007
200799. Methylation status of the wnt antagonist DICKKOPF-1 gene in acute leukemias
ATALAR F., HATIRNAZ O., Sayitoglu M., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.403, (Summary Text)
2007
2007100. WNT5A gene expression and promoter methylation in acute leukemia patients
HATIMAZ O., Sayitoglu M., ATALAR F., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)
2007
2007101. WNT pathway mutations in acute leukemia patients
Sayitoglu M., HATIMAZ O., ATALAR F., ERBILGIN Y., OZBEK U.
12th Congress of the European-Hematology-Association, Vienna, Austria, 7 - 10 June 2007, vol.92, pp.55, (Summary Text)
2006
2006102. Upregulation of FZ5 results in abberant expression of beta-catenin and LEF/TCF complex in acute myeloid leukemia.
Atalar F., Hatirnaz O., Erbilgin Y., Ozbek U., Sayitoglu M., Ozbek U.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108
2006
2006103. Different activation of WNT signaling pathway in B-cell and T-cell acute leukemias.
Sayitoglu M., HATIRNAZ O., Erbilgin Y., Atalar F., Ozbek U.
48th Annual Meeting of the American-Society-of-Hematology, Florida, United States Of America, 9 - 12 December 2006, vol.108, (Summary Text)
2006
2006104. Yüksek FZ5 Ekspresyonu Beta-Catenin/TCF-LEF Kompleksinin Atipik Ekspresyonunu Arttırarak Akut Myeloid Lösemi Gelişiminde Rol Oynar
Atalar F., Sayitoğlu M., Hatirnaz Ng Ö., Erbilgin Y., Özbek U.
XXXII. Ulusal Hematoloji Kongresi, Antalya, Turkey, 8 - 12 November 2006, pp.76, (Full Text)
Books
2025
20251. The Human Genome and Inheritance: Key Concepts
Erbilgin Y., Sayitoğlu M.
in: Pathological Basis of Oral and Maxillofacial Diseases, Khurram Syed Ali,Kujan Omar,Prabhu Soorebettu,SOLUK TEKKEŞİN MERVA, Editor, Willey, Melbourne, pp.227-244, 2025
2024
20242. Germline Predisposition to Childhood Cancers
Sudutan T., ERBİLGİN Y.
in: Cancer: From Genomics to Pharmaceutics, KARAKAŞ ZEYNEP, ERDAL MERYEM SEDEF, SAYİTOĞLU MÜGE, SOLUK TEKKEŞİN MERVA, Editor, Istanbul University Press, pp.147-175, 2024
2023
20233. EPİGENETİK HAFIZA VE EPİGENETİK KALITIM
ERBİLGİN Y., ÖZBEK U.
in: Epigenetik, Hikmet AKGÜL, Editor, Türkiye Klinikleri Tıbbi Genetik, pp.69-74, 2023
2021
20214. Biyobankalar
Erbilgin Y., Uğur İşeri S. A., Özbek U.
in: Tıp Bilişimi, Nilgün Bozbuğa,Sevinç Gülseçen, Editor, Istanbul University, İstanbul, pp.159-169, 2021
2019
20195. Genetikte Temel Kavramlar
ERBİLGİN Y., ÖZBEK U.
in: ”Cerebral Palsy” ve Genetik, Hande Akçakaya, Uğur Özbek, Editor, Boyut, pp.1-8, 2019
2019
20196. GENETİKTE TEMEL KAVRAMLAR
ERBİLGİN Y., ÖZBEK U.
in: Genetik, Güner Hayri Özsan, Müge Sayitoğlu, Editor, Galenos, pp.1-8, 2019
2019
20197. AKUT LENFOBLASTİK LÖSEMİ GENETİĞİ
ERBİLGİN Y.
in: Genetik, Güner Hayri Özsan, Müge Sayitoğlu, Editor, Galenos, pp.78-90, 2019
2017
20178. Biyobankalamada Protokol ve Kalite Kılavuzu
ERBİLGİN Y., UĞUR İŞERİ S. A., Khodzhaev K., Haryanyan G.
İstanbul Medikal Sağlık ve Yayıncılık Hiz. Tic. Ltd. Şti., İstanbul, 2017
2016
20169. Epigenetics, Inflammation and Inflammation Associated Diseases
SAYİTOĞLU M., ERBİLGİN Y.
in: Epigenetics, Yıldız Dinçer, Editor, NOVA Publications , New York, pp.175-211, 2016
Funded Projects
2023 - 2024
2023 - 2024Lenfomaya Germline Yatkınlıkta Yeni Bir Gen: Deltex3l Fonksiyonel Analizleri
TUBITAK Project , 1002 - Quick Support Program
(Project Abstract)
Erbilgin Y., Sayitoğlu M., Hekimoğlu H.(Executive)
2022 - 2024
2022 - 2024İSTisNA Istanbul Solution Platform for Undiagnosed and Rare Diseases
Development Agency
(Project Abstract)
Özbek U.(Executive), Uğur İşeri S. A., Hatırnaz Ng Ö., Erbilgin Y., Ulca P., Alanay Y., et al.
2020 - 2021
2020 - 2021ANALYSIS OF PLURIPOTENCY GENES IN SINGLE LEUKEMIC STEM CELLS (LSCs) IN CHRONIC MYELOID LEUKEMIA
TUBITAK Project , 2219 - Yurt Dışı Doktora Sonrası Araştırma Burs Programı
ERBİLGİN Y.
2019 - 2021
2019 - 2021İSTisNA- İstanbul Tanısız ve NAdir Hastalıklara Çözüm Platformu Fizibilite Raporu Projesi
CB Strateji ve Bütçe Başkanlığı (Kalkınma Bakanlığı) Projesi
Özbek U.(Executive), Uğur İşeri S. A., Satman İ., Hatırnaz Ng Ö., Erbilgin Y.
2015 - 2019
2015 - 2019ADOPT BBMRI-ERIC: the Biobanking and BioMolecular resources Research Infrastructure- European Infrastructure Consortium
EU Supported Other Project
(Project Abstract)
Steinfelder E., Atabey S. N., Özbek U., Erbilgin Y.
2016 - 2018
2016 - 2018Yüksek Riskli Akut Lösemi Hastalarında Tüm Genom Analizi
Project Supported by Higher Education Institutions , BAP Other
ERBİLGİN Y. (Executive), SAYİTOĞLU M., ÖZBEK U., HATIRNAZ NG Ö., FIRTINA S., KARAKAŞ Z.
2015 - 2017
2015 - 2017Geleceğe Yatırım: BİYOBANKA
Project Supported by Other Official Institutions
TUNCER KILINÇ F. N., UĞUR İŞERİ S. A., TÜRKER ŞENER L., ERBİLGİN Y.
2016 - 2016
2016 - 2016Gene expression patterns in relapsed Bcell acute lymphoblastic leukemia and potential therapeutic targets
Project Supported by Higher Education Institutions , BAP Other
ERBİLGİN Y. (Executive), ÖZBEK U., İŞLEK B., HATIRNAZ NG Ö., FIRTINA S., KARAKAŞ Z., et al.
Activities in Scientific Journals
2014 - Present
2014 - Presentİ.Ü. Deneysel Tıp Dergisi
Evaluation Committee Member
Memberships and Roles in Scientific Organizations
2024 - Present
2024 - PresentEuropean Society of Human Genetics
Member
2019 - Present
2019 - PresentTıbbi Genetik Derneği
Member
2016 - Present
2016 - PresentTürk Hematoloji Derneği
Member
2013 - Present
2013 - PresentTürk Biyokimya Derneği
Member
Peer Reviews in Scientific Publications
February 2024
February 2024BMC CANCER
SCI Journal
March 2023
March 2023TURKISH JOURNAL OF HAEMATOLOGY
Journal Indexed in SCI-E
August 2022
August 2022Türk Hematoloji Derneği Kongresi
Journal Indexed in SCI-E
August 2022
August 2022PLOS ONE
Journal Indexed in SCI-E
July 2022
July 2022CANCER INVESTIGATION
Journal Indexed in SCI-E
July 2022
July 2022BMC CANCER
Journal Indexed in SCI-E
March 2019
March 2019Oncology and Therapy
Journal Indexed in SCI-E
February 2019
February 2019Medicine
SCI Journal
February 2017
February 2017Oncology and Therapy
Journal Indexed in SCI-E
January 2017
January 2017Medicine
SCI Journal
Scientific Project Refereeing
November 2022
November 2022R&D Project of Group B
Gebze Technical University, Turkey
Mobility Activity
2020 - 2022
2020 - 2022Post Doc
Post Doc
Université Paris-Sud: Paris XI, France
Congress and Symposium Activities
01 May 2019 - 01 May 2019
01 May 2019 - 01 May 20197 th. International Congress on Leukemia Lymphoma Myeloma
Attendee
-Turkey
01 April 2019 - 01 April 2019
01 April 2019 - 01 April 201913 Balkan Congress of Human Genetics
Attendee
Edirne-Turkey
01 October 2018 - 01 October 2018
01 October 2018 - 01 October 2018IX. International Eurasian Hematology-Oncology Congress
Attendee
İstanbul-Turkey
01 May 2018 - 01 May 2018
01 May 2018 - 01 May 2018International Workshop and Symposium on Biobanks, Istanbul, Turkey
Attendee
İzmir-Turkey
01 June 2017 - 01 June 2017
01 June 2017 - 01 June 201710th International Symposium on Health Informatics and Bioinformatics
Attendee
-Turkey
01 May 2017 - 01 May 2017
01 May 2017 - 01 May 20176th International Congress on Leukemia Lymphoma Myeloma
Attendee
--Seçiniz---Turkey
01 February 2017 - 01 February 2017
01 February 2017 - 01 February 2017European Leukemia Network Meeting
Attendee
Mannheim-Germany
Scholarships
2020 - 2022
2020 - 20222219-Yurt Dışı Doktora Sonrası Araştırma Burs Programı. 1059B191802277
TUBITAK
Citations
Total Citations (WOS): 304
h-index (WOS): 9
Jury Memberships
June-2023
June 2023